Avita Medical
RCEL
71 hedge funds and large institutions have $179M invested in Avita Medical in 2021 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 16 closing their positions.
725% more call options, than puts
Call options by funds: $33K | Put options by funds: $4K
78% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 9
63% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 16
31% more capital invested
Capital invested by funds: $137M → $179M (+$41.9M)
16% more funds holding
Funds holding: 61 → 71 (+10)
7.34% more ownership
Funds ownership: 27.9% → 35.25% (+7.3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$25.4M |
| 2 |
State Street
Boston,
Massachusetts
|
+$7.26M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.56M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.3M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$3.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$5.32M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$5.07M |
| 3 |
PVI
Pura Vida Investments
New York
|
-$2.46M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$1.95M |
RCEL Hedge Fund Activity: Q2 2021 in Review
71 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q2 2021, worth a combined $179M — up 31% from $137M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new RCEL positions and 16 closed out — a net gain of 10 holders — while 16 added to existing stakes and 9 trimmed.
The largest buyer was BlackRock, adding an estimated $25.4M. The largest seller was Millennium Management, exiting entirely with an estimated $5.32M sold.
- 71 institutional investors held Avita Medical (RCEL) as of Q2 2021, up from 61 in Q1 2021.
- Funds reported $179M of Avita Medical stock for Q2 2021, up 31% quarter-over-quarter.
- 26 funds opened new Avita Medical positions in Q2 2021 and 16 closed out, a net change of +10 holders.
- The largest Avita Medical buyer in Q2 2021 was BlackRock, an estimated $25.4M added.
- The largest Avita Medical seller in Q2 2021 was Millennium Management, an estimated $5.32M sold.
Based on aggregated 13F filings for Q2 2021.